Disbrow Lisa S's Form 4 filing
CACI International Inc (CACI) · filed Jul 15, 2026
- Accession no.
- 0001712360-26-000001
- Filed
- Jul 15, 2026, 6:43 AM ET
- Trade date
- Jul 13, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Disbrow Lisa SCIK 0001712360 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | CACI Common Stock | MOption exerciseAcquired | +123 | –F1 | – | 2,452 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | CACI Common Stock | MOption exerciseDisposed | −123 | –F1 | – | 123 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On October 16, 2025, Ms. Disbrow was granted 492 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 123 shares will vest on January 14, 2026, 123 shares on April 14, 2026, 123 shares on July 13, 2026 and 123 shares on October 11, 2026.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.